ALS antisense oligonucleotides

Designing Antisense Oligonucleotides

Antisense Oligonucleotides Targeting Protein

Designing Antisense Oligonucleotides

Antisense oligonucleotides have been used for a number of years to modify the expression of specific genes both in vivo and in vitro (Scanlon et al., 1995). The most potent mode of antisense activity is through RNase H–mediated degradation of RNA (Figure 1). The RNase H– endonuclease specifically cleaves RNA only when it is hybridized as a heteroduplex with DNA. In general, oligonucleotides tha...

Meeting report: antisense oligonucleotides.

The use of antisense oligonucleotides as a therapeutic tool in modulating gene expression represents a newly established strategy for treating diseases. Such oligomers may be designed to complement a region of a specific gene or messenger RNA. Using this approach, oligonucleotides can serve as a potential block of transcription or translation through sequence-specific hybridization with targete...

Acetylcholinesterase Antisense Oligonucleotides (EN101) as a Novel Treatment Strategy for ALS: A Mouse Model Study

Acetylcholinesterase Antisense Oligonucleotides (EN101) as a Novel Treatment Strategy for ALS: A Mouse Model Study Marc Gotkine, Gladis Gilinski, Leah Rozenstein, Oded Abramsky, Zohar Argov, Hanna Rosenmann, Jerusalem, Israel The study investigated the effect of EN101 on a transgenic mouse model of ALS. Previous evidence indicated that acetylcholinesterase (AChE) is involved in ALS. However, AC...